BioCryst Pharmaceuticals Inc.

Analysts Viewpoint

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Biocryst Pharmaceuticals

Analysts Viewpoint

Biocryst Pharmaceuticals Inc’s recent filing unveils that its Director McKee Amy E unloaded Company’s shares for reported $54352.0 on Jun

Stock Earnings

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or

Analysts Viewpoint

Biocryst Pharmaceuticals Inc’s filing revealed that its Director McKee Amy E unloaded Company’s shares for reported $54352.0 on Jun 24

Insiders Updates

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or

Stock Earnings

Biocryst Pharmaceuticals Inc’s filing revealed that its Director McKee Amy E unloaded Company’s shares for reported $54352.0 on Jun 24

Analysts Viewpoint

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or

Stock Earnings

Biocryst Pharmaceuticals Inc.’s recent filing unveils that its Director McKee Amy E unloaded Company’s shares for reported $54352.0 on Jun

Insiders Updates

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Biocryst Pharmaceuticals

Insiders Updates

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Biocryst Pharmaceuticals

Tag: BioCryst Pharmaceuticals Inc.